Total Payments
$50,932
2024 Payments
$14,100
Companies
75
Transactions
950
Medicare Patients
9,091
Medicare Billing
$961,966
Payment Breakdown by Category
Other$22,939 (45.0%)
Food & Beverage$20,699 (40.6%)
Consulting$3,224 (6.3%)
Travel$3,094 (6.1%)
Education$975.31 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,667 | 18 | 44.5% |
| Food and Beverage | $20,699 | 883 | 40.6% |
| Consulting Fee | $3,224 | 11 | 6.3% |
| Travel and Lodging | $3,094 | 11 | 6.1% |
| Education | $975.31 | 26 | 1.9% |
| Honoraria | $272.63 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teleflex LLC | $30,829 | 84 | $0 (2024) |
| Axonics, Inc. | $3,006 | 74 | $0 (2024) |
| Astellas Pharma US Inc | $2,084 | 129 | $0 (2024) |
| Janssen Biotech, Inc. | $846.69 | 42 | $0 (2024) |
| PFIZER INC. | $795.41 | 58 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $784.20 | 35 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $743.99 | 30 | $0 (2024) |
| ABBVIE INC. | $628.17 | 46 | $0 (2024) |
| COLOPLAST CORP | $592.31 | 32 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $586.04 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,100 | 158 | Teleflex LLC ($10,327) |
| 2023 | $21,866 | 171 | Teleflex LLC ($18,217) |
| 2022 | $5,251 | 145 | Teleflex LLC ($1,633) |
| 2021 | $3,339 | 132 | Teleflex LLC ($651.26) |
| 2020 | $1,787 | 80 | Medtronic USA, Inc. ($300.05) |
| 2019 | $1,321 | 78 | Astellas Pharma US Inc ($374.71) |
| 2018 | $1,450 | 102 | Astellas Pharma US Inc ($361.18) |
| 2017 | $1,817 | 84 | Astellas Pharma US Inc ($366.15) |
All Payment Transactions
950 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Urology Gynecology | ||||||
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| 12/20/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $167.66 | General |
| Category: Urology | ||||||
| 12/19/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $21.51 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 12/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: HORMONE THERAPY | ||||||
| 12/16/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/16/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.57 | General |
| 11/27/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $38.83 | General |
| 11/24/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug), PIPELINE | Food and Beverage | In-kind items and services | $43.53 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Genetic Disease | ||||||
| 11/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/14/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: HORMONE THERAPY | ||||||
| 11/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $17.32 | General |
| 11/04/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Continence Care | ||||||
| 10/30/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $36.18 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/30/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Urology Gynecology | ||||||
| 10/28/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/24/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $38.83 | General |
| 10/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,744 | 2,638 | $405,968 | $191,521 |
| 2022 | 29 | 2,306 | 3,288 | $895,927 | $298,001 |
| 2021 | 31 | 2,590 | 3,860 | $918,027 | $305,180 |
| 2020 | 29 | 2,451 | 3,538 | $607,383 | $167,264 |
Total Patients
9,091
Total Services
13,324
Medicare Billing
$961,966
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Office | 2023 | 17 | 100 | $139,840 | $63,509 | 45.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 281 | 358 | $58,104 | $32,620 | 56.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 208 | 302 | $33,760 | $19,440 | 57.6% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Office | 2023 | 17 | 17 | $31,700 | $15,913 | 50.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 97 | $32,460 | $13,130 | 40.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 37 | 43 | $13,363 | $7,574 | 56.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $14,844 | $6,895 | 46.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 45 | $10,254 | $5,841 | 57.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 34 | $7,464 | $3,410 | 45.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 41 | 53 | $6,005 | $2,982 | 49.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 44 | 48 | $7,350 | $2,968 | 40.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 216 | 337 | $6,931 | $2,494 | 36.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 17 | $13,173 | $1,829 | 13.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 445 | 819 | $3,988 | $1,776 | 44.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 16 | 16 | $3,540 | $1,541 | 43.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $3,558 | $1,469 | 41.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 22 | $2,324 | $1,340 | 57.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 13 | 13 | $2,379 | $1,313 | 55.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 72 | 72 | $1,818 | $1,241 | 68.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,370 | $1,133 | 47.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 27 | $1,850 | $1,096 | 59.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 84 | 98 | $1,568 | $789.60 | 50.3% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 14 | 15 | $6,396 | $717.81 | 11.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 20 | $929.00 | $499.60 | 53.8% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Office | 2022 | 35 | 189 | $378,000 | $127,144 | 33.6% |
About Dr. Sabry Mansour, MD
Dr. Sabry Mansour, MD is a Urology healthcare provider based in Lapeer, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326009861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sabry Mansour, MD has received a total of $50,932 in payments from pharmaceutical and medical device companies, with $14,100 received in 2024. These payments were reported across 950 transactions from 75 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,667).
As a Medicare-enrolled provider, Mansour has provided services to 9,091 Medicare beneficiaries, totaling 13,324 services with total Medicare billing of $961,966. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Lapeer, MI
- Active Since 03/31/2006
- Last Updated 11/27/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1326009861
Products in Payments
- UROLIFT (Device) $28,712
- Axonics (Device) $2,234
- UroLift System (Device) $2,030
- XTANDI (Drug) $1,344
- ORGOVYX (Drug) $891.93
- PROVENGE (Drug) $784.20
- Axonics r-SNM System (Device) $650.73
- ERLEADA (Drug) $541.94
- INTERSTIM (Device) $539.01
- Nubeqa (Drug) $487.77
- LYNPARZA (Drug) $476.34
- MYRBETRIQ (Drug) $444.56
- LUPRON DEPOT (Drug) $371.99
- Bulkamid (Device) $370.84
- BOTOX (Biological) $353.93
- KEYTRUDA (Biological) $340.43
- Myrbetriq (Drug) $323.92
- Erleada (Drug) $289.84
- NOCDURNA (Drug) $268.58
- ZYTIGA (Drug) $264.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.